Taipei, Taiwan

Meng-Lun Hsieh

This inventor holds 1 USPTO granted patent. Top assignees: National Health Research Institutes, National Taiwan University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meng-Lun Hsieh. Retrieved from https://idiyas.com/inventor/meng-lun-hsieh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Meng-Lun Hsieh: A Spotlight on His Patents and Career

Introduction: Meng-Lun Hsieh, based in Taipei, Taiwan, is a distinguished inventor recognized for his significant contributions to the field of biomedical innovations. With a focus on developing therapeutic compounds, he holds a notable patent that showcases his expertise and inventive spirit.

Latest Patents: Meng-Lun Hsieh is credited with one patent titled "PTGR2 inhibitors and their use." This patent discloses compounds of a specific formula (I), which have potential applications in treating various health conditions. His innovative approach in this area highlights the importance of research in the advancement of medical therapies.

Career Highlights: Over the years, Meng-Lun Hsieh has made substantial contributions through his work with respected institutions such as the National Health Research Institutes and National Taiwan University. His involvement in these organizations has allowed him to further his research capabilities and collaborate with leading experts in the field.

Collaborations: Throughout his career, Meng-Lun Hsieh has worked alongside esteemed colleagues, including Lun Kelvin Tsou and Ming-Shiu Hung. These collaborations have not only enhanced his research outcomes but have also fostered a rich environment for innovation and discovery.

Conclusion: Meng-Lun Hsieh's dedication to the development of novel therapeutic compounds positions him as a notable figure in the realm of biomedical research. His patent on PTGR2 inhibitors exemplifies his commitment to advancing medical science, making impactful strides towards potential healthcare solutions. With ongoing collaboration and research, he continues to influence the future of innovation in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…